Targeting the RyR2 to Prevent Atrial Fibrillation

Dobromir Dobrev

Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Germany (D.D.).

Department of Medicine, Montreal Heart Institute and Université de Montréal, Montréal, Canada (D.D.).

Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX (D.D.).

留言 (0)

沒有登入
gif